Works matching IS 16745671 AND DT 2024 AND VI 16 AND IP 6

Results: 17

α2⁃巨球蛋白表达下调激活 TGF⁃β/SMADs 信号通路诱导卵巢癌顺铂耐药.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 707, doi. 10.3969/j.issn.1674‐5671.2024.06.11

By:

陆婷婷;
石丽君;
刘萤照;
梁惠婷;
王琪

Publication type:

Article

胃癌手术患者血脂水平与生存预后的相关性：一项回顾性队列研究.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 687, doi. 10.3969/j.issn.1674⁃5671.2024.06.08

By:

郭芝妤;
曹田宇;
王伟东;
郭星娴;
马婉琪;
卢瑗瑗;
赵晓迪;
季刚

Publication type:

Article

ESMO 2024 年会: 肝细胞癌治疗新突破与未来趋势.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 741, doi. 10.3969/j.issn.1674⁃5671.2024.06.16

By:

王进明;
李耀杰;
邱国高;
刘绍平;
刘杰;
游雪梅;
马良;
钟鉴宏

Publication type:

Article

LncRNA PSMA3⁃AS1 调节 miR⁃186⁃5p/SOX4 轴对神经母细胞瘤细胞增殖、迁移和侵袭的影响.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 715, doi. 10.3969/j.issn.1674⁃5671.2024.06.12

By:

安艳晓;
焦晗亮;
祁艳卫;
仲智勇

Publication type:

Article

免疫检查点抑制剂诱导高血糖癌症患者血糖管理的最佳证据总结.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 722, doi. 10.3969/j.issn.1674⁃5671.2024.06.13

By:

蒋媛;
王小艳;
雷蕾;
刘丽华;
吴丹凤;
张思奇;
唐代茸;
樊伶俐;
冯岗;
薛小静

Publication type:

Article

肿瘤基因诊断二代测序生物信息学分析平台本地化建设中国专家共识 (2024年版).

Published in:: Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 638, doi. 10.3969/j.issn.1674‐5671.2024.06.02
Publication type:: Article

胃神经内分泌肿瘤的综合诊治策略及思考.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 681, doi. 10.3969/j.issn.1674⁃5671.2024.06.07

By:

计蓓;
庹必光;
刘雪梅

Publication type:

Article

m<sup>7</sup>G 甲基转移酶 METTL1 在肿瘤中的作用及其机制.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 747, doi. 10.3969/j.issn.1674⁃5671.2024.06.17

By:

李冰冰;
徐克

Publication type:

Article

结直肠黏液腺癌诊疗新进展.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 663, doi. 10.3969/j.issn.1674‑5671.2024.06.05

By:

弓戈;
李昂;
王新;
卢瑗瑗

Publication type:

Article

中晚期肝癌术后患者同期症状网络分析及核心症状识别.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 729, doi. 10.3969/j.issn.1674⁃5671.2024.06.14

By:

黄仕环;
蓝慧玉;
农小莲;
李繁荣;
赵凤娟;
游雪梅

Publication type:

Article

2024 版《ACG 临床指南: 局灶性肝脏病变》解读.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 656, doi. 10.3969/j.issn.1674⁃5671.2024.06.04

By:

林雷珀;
黄志浩;
向邦德;
马良;
黎乐群;
钟鉴宏

Publication type:

Article

1990-2021 年中国子宫颈癌的发病、死亡与疾病负担：过去30年的趋势与未来预测.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 694, doi. 10.3969/j.issn.1674⁃5671.2024.06.09

By:

宣文贞;
巩建敏;
李娜

Publication type:

Article

肿瘤临床试验研究参与者补偿管理中国专家共识 (2024年版).

Published in:: Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 650, doi. 10.3969/j.issn.1674⁃5671.2024.06.03
Publication type:: Article

湖南省二级及以上医院中等长度静脉导管应用及管理现状调查.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 736, doi. 10.3969/j.issn.1674⁃5671.2024.06.15

By:

刘汉卿;
胡永红;
林琴;
魏涛;
袁忠;
李旭英

Publication type:

Article

2020 年山西省肿瘤登记地区恶性肿瘤发病与死亡情况分析.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 700, doi. 10.3969/j.issn.1674⁃5671.2024.06.10

By:

潘宏鑫;
崔王飞;
吕利成;
王新正;
曹凌;
张永贞

Publication type:

Article

胃癌液体活检中肿瘤生物标志物研究进展.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 673, doi. 10.3969/j.issn.1674⁃5671.2024.06.06

By:

付依凡;
王博达;
何阳菘;
卢瑗瑗;
王新

Publication type:

Article

基于整合医学的肿瘤新型生物学分型及其临床应用前景.

Published in:

Chinese Journal of Oncology Prevention & Treatment, 2024, v. 16, n. 6, p. 633, doi. 10.3969/j.issn.1674⁃5671.2024.06.01

By:

曹田宇;
王寅格;
刘妍星;
秦妮平;
吴键;
康晓宇;
刘浩;
高小亮;
陈捷;
聂勇战;
赵晓迪;
卢瑗瑗;
樊代明

Publication type:

Article